FI973457A - Hepatiitti B -rokote - Google Patents

Hepatiitti B -rokote Download PDF

Info

Publication number: FI973457A
Authority: FI; Finland
Prior art keywords: vaccine; hepatitis
Prior art date: 1995-02-25

Application number

FI973457A

Other languages

English (en)

Swedish (sv)

Other versions

FI118118B (fi

FI973457A0 (fi

Inventor

Pierre Hauser

Nathalie Marie-Josephe Garcon

Pierre Desmons

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-25

Filing date

1997-08-22

Publication date

1997-08-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770292&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI973457(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-08-22 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

1997-08-22 Publication of FI973457A publication Critical patent/FI973457A/fi

1997-08-22 Publication of FI973457A0 publication Critical patent/FI973457A0/fi

2007-07-13 Application granted granted Critical

2007-07-13 Publication of FI118118B publication Critical patent/FI118118B/fi

Links

SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
229940124736 hepatitis-B vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FI973457A 1995-02-25 1997-08-22 Hepatiitti B -rokote FI118118B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB9503863		1995-02-25
GBGB9503863.4A GB9503863D0 (en)	1995-02-25	1995-02-25	Vaccine compositions
PCT/EP1996/000681 WO1996026741A1 (en)	1995-02-25	1996-02-15	Hepatitis b vaccine
EP9600681		1996-02-15

Publications (3)

Publication Number	Publication Date
FI973457A true FI973457A (fi)	1997-08-22
FI973457A0 FI973457A0 (fi)	1997-08-22
FI118118B FI118118B (fi)	2007-07-13

Family

ID=10770292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI973457A FI118118B (fi)	1995-02-25	1997-08-22	Hepatiitti B -rokote

Country Status (36)

Country	Link
US (1)	US5972346A (fi)
EP (1)	EP0810877B1 (fi)
JP (1)	JP3881015B2 (fi)
KR (1)	KR100365373B1 (fi)
CN (1)	CN1101225C (fi)
AP (1)	AP766A (fi)
AR (1)	AR002279A1 (fi)
AT (1)	ATE209045T1 (fi)
AU (1)	AU695921B2 (fi)
BG (1)	BG101851A (fi)
BR (1)	BR9607458A (fi)
CA (1)	CA2212552C (fi)
CZ (1)	CZ288417B6 (fi)
DE (1)	DE69617211T2 (fi)
DK (1)	DK0810877T3 (fi)
EA (1)	EA199700126A1 (fi)
ES (1)	ES2166879T3 (fi)
FI (1)	FI118118B (fi)
GB (1)	GB9503863D0 (fi)
HK (1)	HK1004117A1 (fi)
HU (1)	HU224832B1 (fi)
IL (1)	IL117249A (fi)
MA (1)	MA23814A1 (fi)
MX (1)	MX9706450A (fi)
MY (1)	MY113428A (fi)
NO (1)	NO319394B1 (fi)
NZ (1)	NZ302674A (fi)
OA (1)	OA10612A (fi)
PL (1)	PL182679B1 (fi)
PT (1)	PT810877E (fi)
SA (1)	SA96160633B1 (fi)
SK (1)	SK115097A3 (fi)
TR (1)	TR199700849T1 (fi)
TW (1)	TW467745B (fi)
WO (1)	WO1996026741A1 (fi)
ZA (1)	ZA961460B (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6620414B2 (en) *	1992-03-27	2003-09-16	Smithkline Beecham Biologicals (S.A.)	Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
FR2711670B1 (fr)	1993-10-22	1996-01-12	Pasteur Institut	Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
US6488934B1 (en) *	1995-02-25	2002-12-03	Smithkline Beecham Biologicals S.A.	Hepatitis B vaccine
US20010014331A1 (en) *	1996-11-07	2001-08-16	Smithkline Beecham Biologicals S.A.	Acellular pertussis vaccine with diphthriae-and tetanus-toxoids
GB9809507D0 (en) *	1998-05-01	1998-07-01	Smithkline Beecham Biolog	Novel composition
US20030049268A1 (en)	1998-05-01	2003-03-13	Smithkline Beecham Biologicals S.A.	Novel composition
AU761899B2 (en)	1998-05-22	2003-06-12	Ottawa Health Research Institute	Methods and products for inducing mucosal immunity
US6306404B1 (en)	1998-07-14	2001-10-23	American Cyanamid Company	Adjuvant and vaccine compositions containing monophosphoryl lipid A
EP1126876B1 (en) *	1998-10-16	2007-03-21	GlaxoSmithKline Biologicals S.A.	Adjuvant systems and vaccines
CU22871A1 (es) *	1998-12-02	2003-10-21	Ct Ingenieria Genetica Biotech	Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal
WO2000037104A1 (en) *	1998-12-23	2000-06-29	Merck & Co., Inc.	Improved recombinant hepatitis b surface antigen
KR100922031B1 (ko)	1999-04-19	2009-10-19	글락소스미스클라인 바이오로지칼즈 에스.에이.	백신
US6635261B2 (en)	1999-07-13	2003-10-21	Wyeth Holdings Corporation	Adjuvant and vaccine compositions containing monophosphoryl lipid A
CU23031A1 (es) *	2002-01-24	2005-02-23	Ct Ingenieria Genetica Biotech	Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
US20090214592A1 (en) *	2005-02-16	2009-08-27	O'hagan Derek	Adjuvant composition comprising aluminium phosphate and 3D-MPL
BRPI0614254A2 (pt) *	2005-08-02	2011-03-15	Novartis Vaccines & Diagnostic	redução de interferência entre adjuvantes contendo óleo e antìgenos contendo tensoativos
CN102727885A (zh)	2005-11-04	2012-10-17	诺华疫苗和诊断有限公司	包含颗粒佐剂和免疫增强剂组合的流感疫苗
PL1945252T3 (pl)	2005-11-04	2013-11-29	Seqirus Uk Ltd	Szczepionki zawierające oczyszczone antygeny powierzchniowe otrzymane z wirusów grypy hodowanych w hodowli komórkowej i skwalen jako adiuwant
WO2007052155A2 (en)	2005-11-04	2007-05-10	Novartis Vaccines And Diagnostics Srl	Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
EP1951298A1 (en)	2005-11-04	2008-08-06	Novartis Vaccines and Diagnostics S.r.l.	Adjuvanted influenza vaccines including cytokine-inducing agents
CN100415294C (zh) *	2005-12-23	2008-09-03	中国农业大学	一种治疗和/或预防乙肝的药物
EA015271B1 (ru)	2006-01-27	2011-06-30	Новартис Вэксинс Энд Диагностикс Гмбх & Ко Кг	Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса
US8173657B2 (en)	2006-03-23	2012-05-08	Novartis Ag	Imidazoquinoxaline compounds as immunomodulators
WO2007110776A1 (en)	2006-03-24	2007-10-04	Novartis Vaccines And Diagnostics Gmbh & Co Kg	Storage of influenza vaccines without refrigeration
EP1862176A1 (de) *	2006-05-31	2007-12-05	Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH	Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) *	2006-06-01	2007-12-05	Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH	Ein Verfahren zur Herstellung einer Impfzusammensetzung
US20100015168A1 (en)	2006-06-09	2010-01-21	Novartis Ag	Immunogenic compositions for streptococcus agalactiae
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
CA3016948A1 (en)	2006-09-11	2008-03-20	Seqirus UK Limited	Making influenza virus vaccines without using eggs
CN101553252A (zh)	2006-12-06	2009-10-07	诺华有限公司	包含来自于四株流感病毒的抗原的疫苗
PL2185191T3 (pl)	2007-06-27	2013-02-28	Novartis Ag	Szczepionki przeciwko grypie o małej zawartości dodatków
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
CN101971030A (zh)	2007-12-24	2011-02-09	诺华有限公司	流感吸附疫苗的试验
EP3178490B1 (en)	2009-07-15	2022-04-20	GlaxoSmithKline Biologicals S.A.	Rsv f protein compositions and methods for making same
PL2667892T3 (pl)	2011-01-26	2019-09-30	Glaxosmithkline Biologicals Sa	Schemat szczepień przeciwko rsv
US9452212B2 (en)	2011-04-14	2016-09-27	Dynavax Technologies Corporation	Methods and compositions for eliciting an immune response against hepatitis B virus
SG194755A1 (en)	2011-05-13	2013-12-30	Novartis Ag	Pre-fusion rsv f antigens
US11013795B2 (en)	2015-06-26	2021-05-25	Seqirus UK Limited	Antigenically matched influenza vaccines
CN113423423B (zh)	2018-11-13	2024-08-13	变异生物技术公司	用于治疗乙型肝炎的免疫原性组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4912094B1 (en) *	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
DE69031556T2 (de) *	1989-07-25	1998-05-14	Smithkline Beecham Biologicals S.A., Rixensart	Antigene sowie Verfahren zu deren Herstellung
DE69226375T2 (de) *	1991-05-29	1998-12-03	Origin Medsystems, Inc., Menlo Park, Calif.	Retraktor-vorrichtung fuer endoskopische chirurgie
MA22842A1 (fr) *	1992-03-27	1993-10-01	Smithkline Beecham Biolog	Procede de preparation de compositions de vaccin.
PT835663E (pt) *	1992-05-23	2010-01-04	Glaxosmithkline Biolog Sa	Vacinas combinadas compreendendo o antigénio de superfície da hepatite b e outros antigénios
AU685443B2 (en) *	1993-03-23	1998-01-22	Smithkline Beecham Biologicals (Sa)	Vaccine compositions containing 3-O deacylated monophosphoryl lipid A
GB9311536D0 (en) *	1993-06-04	1993-07-21	Unilever Plc	Hot soluble low density extractable food product

1995
- 1995-02-25 GB GBGB9503863.4A patent/GB9503863D0/en active Pending
1996
- 1996-02-14 MY MYPI96000567A patent/MY113428A/en unknown
- 1996-02-15 CN CN96192146A patent/CN1101225C/zh not_active Expired - Fee Related
- 1996-02-15 PL PL96321966A patent/PL182679B1/pl unknown
- 1996-02-15 EA EA199700126A patent/EA199700126A1/ru unknown
- 1996-02-15 CA CA002212552A patent/CA2212552C/en not_active Expired - Fee Related
- 1996-02-15 ES ES96904814T patent/ES2166879T3/es not_active Expired - Lifetime
- 1996-02-15 AP APAP/P/1997/001060A patent/AP766A/en active
- 1996-02-15 JP JP52598896A patent/JP3881015B2/ja not_active Expired - Fee Related
- 1996-02-15 HU HU9801242A patent/HU224832B1/hu not_active IP Right Cessation
- 1996-02-15 SK SK1150-97A patent/SK115097A3/sk unknown
- 1996-02-15 AU AU48780/96A patent/AU695921B2/en not_active Ceased
- 1996-02-15 EP EP96904814A patent/EP0810877B1/en not_active Expired - Lifetime
- 1996-02-15 PT PT96904814T patent/PT810877E/pt unknown
- 1996-02-15 CZ CZ19972674A patent/CZ288417B6/cs not_active IP Right Cessation
- 1996-02-15 DE DE69617211T patent/DE69617211T2/de not_active Expired - Lifetime
- 1996-02-15 AT AT96904814T patent/ATE209045T1/de active
- 1996-02-15 DK DK96904814T patent/DK0810877T3/da active
- 1996-02-15 BR BR9607458A patent/BR9607458A/pt not_active IP Right Cessation
- 1996-02-15 NZ NZ302674A patent/NZ302674A/xx not_active IP Right Cessation
- 1996-02-15 TR TR97/00849T patent/TR199700849T1/xx unknown
- 1996-02-15 WO PCT/EP1996/000681 patent/WO1996026741A1/en active IP Right Grant
- 1996-02-15 KR KR1019970705880A patent/KR100365373B1/ko not_active IP Right Cessation
- 1996-02-15 US US08/894,643 patent/US5972346A/en not_active Expired - Lifetime
- 1996-02-22 AR ARP960101469A patent/AR002279A1/es active IP Right Grant
- 1996-02-23 IL IL11724996A patent/IL117249A/xx not_active IP Right Cessation
- 1996-02-23 MA MA24171A patent/MA23814A1/fr unknown
- 1996-02-23 ZA ZA961460A patent/ZA961460B/xx unknown
- 1996-02-26 TW TW085102154A patent/TW467745B/zh not_active IP Right Cessation
- 1996-03-02 SA SA96160633A patent/SA96160633B1/ar unknown
1997
- 1997-08-02 OA OA70066A patent/OA10612A/en unknown
- 1997-08-22 MX MX9706450A patent/MX9706450A/es unknown
- 1997-08-22 FI FI973457A patent/FI118118B/fi not_active IP Right Cessation
- 1997-08-22 NO NO19973873A patent/NO319394B1/no not_active IP Right Cessation
- 1997-08-25 BG BG101851A patent/BG101851A/xx unknown
1998
- 1998-04-28 HK HK98103600A patent/HK1004117A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL117249A0 (en)	1996-06-18
NO973873D0 (no)	1997-08-22
CA2212552A1 (en)	1996-09-06
AU4878096A (en)	1996-09-18
PL321966A1 (en)	1998-01-05
PT810877E (pt)	2002-04-29
MX9706450A (es)	1998-07-31
ZA961460B (en)	1996-08-29
NZ302674A (en)	1999-01-28
IL117249A (en)	2000-11-21
PL182679B1 (pl)	2002-02-28
BG101851A (en)	1998-04-30
BR9607458A (pt)	1998-06-30
ATE209045T1 (de)	2001-12-15
AP766A (en)	1999-09-17
SK115097A3 (en)	1998-02-04
KR19980702480A (ko)	1998-07-15
WO1996026741A1 (en)	1996-09-06
GB9503863D0 (en)	1995-04-19
EP0810877A1 (en)	1997-12-10
ES2166879T3 (es)	2002-05-01
DK0810877T3 (da)	2002-02-25
MA23814A1 (fr)	1996-10-01
HUP9801242A3 (en)	2000-08-28
DE69617211T2 (de)	2002-07-25
HU224832B1 (en)	2006-03-28
FI118118B (fi)	2007-07-13
MY113428A (en)	2002-02-28
TW467745B (en)	2001-12-11
AP9701060A0 (en)	1997-10-31
OA10612A (en)	2002-08-29
EA199700126A1 (ru)	1998-02-26
NO973873L (no)	1997-08-22
NO319394B1 (no)	2005-08-08
HK1004117A1 (en)	1998-11-20
CN1176604A (zh)	1998-03-18
JPH11501018A (ja)	1999-01-26
US5972346A (en)	1999-10-26
CZ288417B6 (en)	2001-06-13
CZ267497A3 (cs)	1998-02-18
TR199700849T1 (xx)	1998-01-21
SA96160633B1 (ar)	2005-10-15
CN1101225C (zh)	2003-02-12
DE69617211D1 (en)	2002-01-03
CA2212552C (en)	2006-07-11
AR002279A1 (es)	1998-03-11
EP0810877B1 (en)	2001-11-21
FI973457A0 (fi)	1997-08-22
KR100365373B1 (ko)	2003-07-07
AU695921B2 (en)	1998-08-27
JP3881015B2 (ja)	2007-02-14
HUP9801242A1 (hu)	1998-08-28

Publication	Publication Date	Title
ATE209045T1 (de)	2001-12-15	Hepatitis b impfstoff
NO976060D0 (no)	1997-12-23	Vaksiner mot hepatitt C
NO20003303L (no)	2000-08-04	Vaksine
BR9711853A (pt)	1999-08-24	Vacinas
KR970704468A (ko)	1997-09-06	폴리에피토프 백신(polyepitope vaccines)
ID20399A (id)	1998-12-10	Vaksin influensa
DE69126606D1 (de)	1997-07-24	Vakzine
DK0736303T3 (da)	2000-01-10	Interferonopløsning
DE69510024D1 (de)	1999-07-08	Spritze
FI944052A (fi)	1994-09-02	Oraalinen rokote
EP0967993A4 (en)	2001-04-18	ANTI-COCAINE VACCINE
DE69630611D1 (de)	2003-12-11	Antigenische präparationen
DE69509766D1 (de)	1999-06-24	Mikroemulsionen
DE69628167D1 (de)	2003-06-18	Spezifische oligonukleotide fuer hepatitis c-virus
IT1276662B1 (it)	1997-11-03	Vaccini polinucleotidici
NO933600D0 (no)	1993-10-08	Termostabile virus
ITMI950511A0 (it)	1995-03-16	Fotodensitometro parallelo perfezionato
SI0810877T1 (en)	2002-06-30	Hepatitis b vaccine
DE69326536D1 (de)	1999-10-28	Antitumor Impfstoff
FI944558A0 (fi)	1994-09-30	Virus
UA24703A (uk)	1998-10-30	Емітерний повторювач
NO980721D0 (no)	1998-02-20	Vaksiner
BR7502544U (pt)	1998-05-05	Easy baby
KR970703417A (ko)	1997-07-03	유두종 바이러스 백신(Papillomavirus vaccines)
SE9501165D0 (sv)	1995-03-31	Hållaranordning

Legal Events

Date	Code	Title	Description
2007-07-13	FG	Patent granted	Ref document number: 118118 Country of ref document: FI
2013-09-17	MM	Patent lapsed

Date

Code

Title

Description

2007-07-13

Patent granted

Ref document number: 118118

Country of ref document: FI

2013-09-17

Patent lapsed